PR

Pranjali Rajiv Mandekar

Active Director Director DIN 09513446
DIN 09513446 First appointment Feb 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2022
Shareholding value •••• Premium profile

About Pranjali Rajiv Mandekar

Data last updated:

Pranjali Rajiv Mandekar is a Director at Leniency Animal Health Private Limited (since 2022). The company operates in Chemicals. Leniency Animal Health Private Limited reported revenue of ₹10.7 Lakh (FY 2024).

DIN 09513446
Primary Designation Director
Industry Chemicals
First Appointment 21 Feb 2022
Oldest Company Age 4 yrs
Largest company Leniency Animal Health Private Limited · ₹10.7 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Feb 20222022₹10.7 Lakh (FY 2024)Active

Board colleagues of Pranjali Rajiv Mandekar

Directorship timeline

Open interactive timeline →
Leniency Animal Health Private Limited
Premium access

Shareholding and investment profile for Pranjali Rajiv Mandekar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pranjali Rajiv Mandekar

Pranjali Rajiv Mandekar currently holds 1 directorship: Leniency Animal Health Private Limited (Director, since 21 Feb 2022, revenue ₹10.7 Lakh (FY 2024)).

Pranjali Rajiv Mandekar was first appointed on 21 Feb 2022 as Director at Leniency Animal Health Private Limited.

The current boards of Pranjali Rajiv Mandekar's companies include Monali Prabhakar Mardane (Leniency Animal Health Private Limited), Sarika Vikram Khatke (Leniency Animal Health Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available